Results 151 to 160 of about 4,991 (245)

Oral Angiolymphoid Hyperplasia With Eosinophilia Exhibiting Cutaneous‐Type Histopathologic Features: Clinical Regression Following Hormonal Withdrawal and a 50‐Year Review

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 6, Page 491-501, June 2026.
Case report of a 30‐year‐old female. Asymptomatic, red‐purple hyperplastic lesion extending from teeth 21 to 25, with bleeding upon manipulation. Differential diagnosis included: inflammatory gingival hyperplasia, plasma cell gingivitis, leukemia, and Wegener's granulomatosis.
Pedro Vinícius Santos de Jesus   +8 more
wiley   +1 more source

Drug Induced Gingival Overgrowth and Its Management

open access: yes, 2013
Gingival overgrowth (GO) that associated with phenytoin tharapy was first reported in the dental literature in 1939 by Kimball.
TÜRKMEN, Aydın   +4 more
core  

Drug-induced gingival overgrowth impeding oral tracheal intubation. [PDF]

open access: yesAnaesth Rep, 2022
Khodadad-Hossaini A   +2 more
europepmc   +1 more source

Calcium Channel Blockers Induced Gingival Overgrowth: A Comprehensive Review from a Dental Perspective. [PDF]

open access: yesJ Int Soc Prev Community Dent, 2022
Damdoum M   +3 more
europepmc   +1 more source

Drug-induced gingival overgrowth in renal transplants patients. [PDF]

open access: yesOpen Med (Wars)
Lomelí-Martínez SM   +8 more
europepmc   +1 more source

Drug-induced gingival overgrowth in cardiovascular patients. [PDF]

open access: yesWorld J Cardiol, 2021
Bajkovec L   +3 more
europepmc   +1 more source

Are inflammatory cytokines potential mediators of phenytoin-induced gingival overgrowth ?

open access: yes, 2001
The levels of interleukin-1beta, tumour necrosis factor-alpha, and interleukin 6 in gingival crevicular fluid of phenytoin-treated patients (from sites exhibiting overgrowth and sites not exhibiting overgrowth) and control subjects were investigated. Six
Nurcan Buduneli   +5 more
core  

Home - About - Disclaimer - Privacy